Mr. Frank Gleeson has more than 20 years of leadership and business building experience as an operating executive and venture capitalist. During his career, he has completed more than $300 million in financing and partnering transactions. Mr. Gleeson is past chair of the board of the Stem Cell Network of Canada and in 2003 was recognized as a Technology Pioneer by the World Economic Forum. He has a number of entrepreneurial interests in the biomedical area outside of cancer. His previous experience includes roles as CEO of a professional services firm, as founding CEO of MDS Proteomics Inc. and as a senior vice president and partner at MDS Capital Corp. where he founded a dozen companies. Prior to MDS, he had a 16-year career with Imperial Chemical Industries PLC (ICI), both in Canada and the U.K., during which he was involved in technology commercialization in numerous fields. Mr. Gleeson holds an MBA degree from York University in Toronto.